3,4-dihydroxyphenylacetic acid and nefiracetam

3,4-dihydroxyphenylacetic acid has been researched along with nefiracetam in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dell'Anna, E; Kojima, H; Lindqvist, E; Luthman, J; Olson, L; Shiotani, T; Tachizawa, H1
Kojima, H; Taniguchi, K; Watabe, S1
Kameyama, T; Mamiya, T; Nabeshima, T; Shiotani, T; Tanaka, T; Yamada, K1

Other Studies

3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and nefiracetam

ArticleYear
Effects of DM-9384, a pyrrolidone derivative, on ischemia-induced changes in the central monoamine systems.
    Pharmacology, biochemistry, and behavior, 1992, Volume: 41, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain Chemistry; Brain Ischemia; Central Nervous System Agents; Gerbillinae; Homovanillic Acid; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Pyrrolidinones; Serotonin

1992
Improvement of impaired brain monoamine metabolism by the cognition-enhancing agent nefiracetam after microsphere-induced cerebral embolism in rats.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:2A

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Biogenic Monoamines; Brain Chemistry; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Intracranial Embolism and Thrombosis; Male; Microspheres; Nerve Tissue Proteins; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Wistar; Serotonin

1994
Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats.
    British journal of pharmacology, 1999, Volume: 126, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amyloid beta-Peptides; Animals; Avoidance Learning; Biogenic Monoamines; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Frontal Lobe; Hippocampus; Homovanillic Acid; Learning; Learning Disabilities; Male; Maze Learning; Memory Disorders; Motor Activity; Peptide Fragments; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Wistar

1999